VIM and kidney cancer: We further carried out IHC analyses of typical immune markers in kidney cancer, testicular cancer, brain glioma and uterine carcinoma through HPA database, and it revealed that compared with the corresponding non-tumor tissues, the immune markers HIF1A, IDH1, AFP and VIM were highly expressed in these four cancer tissues, respectively (Figure S5A).